Reported Reactions

Devices › Percutaneously delivered prostheses and tricuspid valves

Device brand name · Percutaneously delivered prostheses and tricuspid valves

EVOQUE Valve: medical device reports filed with FDA

386 reports name it, 2026–2026. Manufacturer given most often on reports: Edwards Lifesciences. Product code NPW.

386
device reports naming the brand
0% of all MAUDE reports · about 386 a year
386
reports, 12 months to August 2026
0 in the 12 months before
0.3%
classified as malfunction
2.7% across the product code
8.5%
classified as death, as reported
33 reports · not verified by FDA

FDA's MAUDE database holds 386 reports that name the brand "EVOQUE Valve" (percutaneously delivered prostheses and tricuspid valves), received between January 2026 and August 2026; the manufacturer given most often on reports is Edwards Lifesciences. Spellings of one product vary from report to report.

386 reports arrived in the 12 months to August 2026, with none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (91.2%), death (8.5%) and malfunction (0.3%); across all percutaneously delivered prostheses and tricuspid valves reports (product code NPW) death is recorded in 8.1% and malfunction in 2.7%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are insufficient device problem information (51%), patient device interaction problem (34.5%) and migration (6.7%). The patient problems coded most often are heart block, appropriate clinical signs, symptoms and conditions term/code not available and bradycardia. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0114228Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 0Sep 2024: 0Oct 2024: 0Nov 2024: 0Dec 2024: 02025Jan 2025: 0Feb 2025: 0Mar 2025: 0Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 0Aug 2025: 0Sep 2025: 0Oct 2025: 0Nov 2025: 0Dec 2025: 02026Jan 2026: 4Feb 2026: 18Mar 2026: 228Apr 2026: 24May 2026: 10Jun 2026: 33Jul 2026: 47Aug 2026: 22

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type, as classified on the report

Death8.5%33
Injury91.2%352
Malfunction0.3%1
Other0%0
Not given0%0

Who filed the report

Manufacturer report99.7%385
Voluntary report0.3%1
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 1,007 reports carrying product code NPW. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Insufficient device problem information19751%22.1%
Patient device interaction problem13334.5%45.7%
Migrationthe device moved from where it was placed266.7%9.6%
Malposition of device123.1%11.5%
Perivalvular leak71.8%2.6%
Device-device incompatibility51.3%2.3%
Device stenosis20.5%0.5%
Intravalvular regurgitation20.5%2.8%
Difficult to open or close10.3%0.1%
Gradient increase10.3%0.4%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Heart block22658.5%
Appropriate clinical signs, symptoms and conditions term/code not available4311.1%
Bradycardiaslow heart rate236%
Foreign body embolism225.7%
Thrombosis/thrombus174.4%
Tricuspid valve insufficiency/ regurgitation133.4%
Heart failure/congestive heart failure112.8%
Arrhythmia92.3%
Cardiac perforation71.8%
Asystole51.3%
Cardiac arrestthe heart stopped30.8%
Endocarditis20.5%
Tricuspid valve stenosis20.5%
Cardiovascular dysfunction/insufficiency10.3%
Coronary obstruction/occlusion10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureEVOQUE ValveProduct code NPWAll MAUDE reports
Reports3861,00726,136,888
Share of that pool—38.3%0%
Classified as death, per 1,000 reports85819
Classified as injury91.2%89.2%36.2%
Classified as malfunction0.3%2.7%62.3%
Filed by the manufacturer99.7%99.4%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code NPW

BrandReportsLatest 12 monthsClassified as death
EVOQUE Tricuspid Valve Replacement System5131816%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about EVOQUE Valve reports

How many FDA reports name EVOQUE Valve?

386 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 386 in the latest 12 months.

What kinds of events are reported?

injury (91.2%), death (8.5%) and malfunction (0.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

insufficient device problem information (51%), patient device interaction problem (34.5%), migration (6.7%), malposition of device (3.1%) and perivalvular leak (1.8%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (99.7%) and voluntary reports (0.3%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that EVOQUE Valve was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.